Remeglurant

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Remeglurant
Remeglurant structure.png
Clinical data
SynonymsMRZ-8456
ATC code
  • None
Identifiers
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC17H15BrN4O
Molar mass371.231 g/mol g·mol−1
3D model (JSmol)

Remeglurant (INN; developmental code name MRZ-8456) is a drug which acts as a selective antagonist of the mGlu5 receptor.[1][2][3] It is under development by Merz Pharmaceuticals for the treatment of drug-induced dyskinesia but no development has been reported since at least 2016.[3]

See also[edit]

References[edit]

  1. ^ World Health Organization (2013). "International Nonproprietary Names for Pharmaceutical Substances (INN): Proposed INN: List 109" (PDF). WHO Drug Information. World Health Organization. 27 (2).
  2. ^ Danysz W, et al. Substituted pyrazolo[1,5-A]pyrimidines as metabotropic glutamate receptor modulators. US Patent 7985753, 4 August 2006.
  3. ^ a b http://adisinsight.springer.com/drugs/800045269

External links[edit]